Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors

D Parry1, D Mahony, K Wills

  • 1DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, California 94304, USA.

Insights

Cyclin D-CDK complexes control cell cycle progression. INK4 proteins inhibit these complexes, but p21 and p27 family members promote their formation by counteracting INK4 effects.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • D-type cyclins and their partners CDK4/CDK6 regulate cell cycle G0-G1-S transition.
  • This process involves retinoblastoma protein (pRB) phosphorylation and inactivation.
  • INK4 proteins negatively regulate cyclin D-CDK complex assembly.

Purpose of the Study:

  • To investigate the specific interactions between INK4 proteins, p21/p27 family members, and CDK4/CDK6.
  • To elucidate the mechanisms by which INK4 and p21/p27 proteins modulate cyclin D-CDK complex formation and stability.

Main Methods:

  • In vitro association assays to study protein complex formation.
  • Analysis of protein complex stability in proliferating cells.
  • Overexpression studies in 293 cells to assess ternary complex formation.

Main Results:

  • All four INK4 proteins bind CDK4/CDK6 in vitro.
  • Only p16(INK4a) forms stable binary complexes with CDK4/CDK6 in proliferating cells.
  • p21(CIP1) and p27(KIP1) stably associate with CDK4 in cyclin-containing complexes, suggesting an equilibrium.
  • p21(CIP1) overexpression promotes ternary cyclin D-CDK4-p21(CIP1) complex formation.

Conclusions:

  • INK4 proteins differentially associate with CDK4 and CDK6.
  • CDK4 exists in equilibrium between INK4-bound and p21/p27-bound states.
  • p21 family members promote D-type cyclin-CDK associations by counteracting INK4 proteins.

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...